Search Results
Results found for "Dr. Juan Jose Fung"
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
activity becomes so dominated by experiments, data nuance, and scientific discourse that the organization loses
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
This week in Terry’s Corner, Dr. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you DR curves shift to the right with no loss of maximal effect. Each subscription includes: Weekly deep dives from Dr. Consider this: Two dose-response curves, side by side.
- Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi...
October 2022 Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages "The fungal pathogen Histoplasma capsulatum (Hc) invades, replicates within, and destroys and release of small peptide fragments such as C3a, a role for C3aR in macrophage interactions with fungi phagocytosis of bacteria and latex beads, it is critical for optimal macrophage capture of pathogenic fungi Hc-macrophage interactions and uncover a novel and specific role for C3aR in macrophage recognition of fungi
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Jan Steyaert will be presented with the Gabbay Award at Brandeis University on October 27 when he will
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced today the dosing
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
That choice determines whether you risk over- or under-dosing, miss safety windows, or miss therapeutic Dr. Recognizing how your ligand interacts with the receptor lets you predict safety margins, dose–response stay ahead of the science 🧠 Content built for biotech, pharma & academia 💬 Live monthly AMA with Dr Kenakin 💎 $2999/year — one conference cost = 12 months of expert training Premium Dr.
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
When PK is misunderstood early, Dr. derail programs Every therapeutic area—CNS, cardiovascular, GI—faces the same core PK constraints Dr How frequently must it be dosed to maintain effective exposure? Across therapeutic classes, Dr. small molecules, but protein binding, transporters, and tissue architecture play decisive roles Dr Why Terry’s Corner Terry’s Corner delivers weekly pharmacology lectures from Dr.
- The Truth About GPCR Product Launches: Years in the Making
Featuring logos from Dr. GPCR and Revvity. Dr. The fun is what you do with the other 10%. 🎯 From Launch to Legacy For Dr. Want to hear Dr. Trinquet tell the story in his own words? GPCR Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Dr. Frame your strategy, then let the serendipity occur.” — Dr. Want to hear Dr. Trinquet tell the story in his own words? Listen to the full podcast episode here ⸻ More about Revvity pHSense Reagents GPCR Reagents Revvity on Dr GPCR Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Dr. Dr. Dr. Dr. Dr.
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
March 2022 Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment medicines targeting G-protein coupled receptors (GPCRs), today announced that the first subjects have been dosed
- Innovative Data-Driven Solutions: The pHSense Revolution
For Dr. Solubility poses significant challenges. You’re just changing how bright it is—and how long it glows,” said Dr. Eric Trinquet. Listen to the full podcast episode here ⸻ More about Revvity pHSense Reagents GPCR Reagents Revvity on Dr GPCR Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
This week’s Dr. Emerging Voices in GPCR Biology; Domain Therapeutics patents new PAR2 antagonists. 🔍 This Week in Dr 🎥 Live AMA with Dr. Kenakin — October 30, 12 PM EST Join Dr. say in the topics covered next Weekly updates that keep your knowledge sharp Monthly live AMAs with Dr Listen to the episode ➤ Why Dr.
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
March 2022 ERNEST has established an Emergency Fund for Ukrainian researchers.
- How Schild Analysis Protects Your Conclusions in GPCR Research
In this week’s lesson, Dr. Access this week’s key insight ➤ Dr. Dr. 👉 Access this week’s full Premium Edition here ➤ What Members Say “Dr. See you in the Ecosystem, Dr. GPCR Team
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
However, blind assessments of ligand pose quality and affinity prediction have thus far not provided Median ligand RMSD values for top-scored poses were 1.2 Å and 2.0 Å for self-docking and StateMatch/FunctionMatch
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
In the full lecture, Dr. Linearity of the Schild regression (log(DR–1) vs. antagonist concentration). As Dr. Derive dose ratios from those sections only. Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr.
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
Dosing regimens aligned with biology, not just exposure. 🎥 Next Week's Release: The First AMA Session The first Ask-Me-Anything with Dr. course topics Weekly new releases — always fresh, always relevant Live monthly AMA sessions with Dr , pharma, and academia 💎 $2999/year — one conference cost = a full year of expert training Premium Dr Monthly AMAs where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
Plus, check out the latest Dr. GPCR tools and key moves in the biotech world. Dr. Become a Dr. GPCR Ambassador - Share & refer with Dr. GPCR. Join the Affiliate Program Your Shortcut to Dr. The Dr. Best wishes, The Dr. GPCR Team
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
In Episode 168 of the Dr. GPCR Podcast, Dr. And that mindset is precisely what makes their new partnership with Dr. GPCR so powerful. ” — Dr. That’s the mission. ” — Dr. Maria Majellaro Now, as official partners of the Dr. Keyword Cloud: GPCR data platform , fluorescent ligands , assay development , GPCR research community , Dr
- How GPCR Collaboration Built an Innovation Engine
Funding models rewarded independence, not shared resources. The Power of GPCR Collaboration: Funding as a Force Multiplier Collaboration sounds warm and fuzzy. Shared funding gave us leverage. This changed not just what got funded, but what was possible . competitive advantage. 🎧 Listen to the full episode: Leadership, Luck, and GPCR Signaling 🔓 Join Dr
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
Dr. Maria Majellaro’s story, shared in Episode 168 of the Dr. ” — Dr. Maria Majellaro Maria didn’t always know she’d end up in a startup. ” — Dr. With the new Dr. . 👉 Explore Celtarys’ tools and partnership with Dr.
- New Podcast, Sweet Structures & $2.2B GPCR Moves
Hello Sweet GPCR Enthusiasts, This week at Dr. GPCR: a new podcast episode with Dr. Ben Clements, a tour of our official Dr. Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. The official Dr. GPCR Store is live! Best wishes, The Dr. GPCR Team
- New Tools, Smart Signals, and The Kenakin Brief
, we’re spotlighting Celtarys Research, our newest partner, featured in a blog and podcast with CSO Dr After 40+ years and 250 publications, Dr. Dr. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Stay curious, The Dr. GPCR Team
- 📰 GPCR Weekly News, January 15 to 21, 2024
This week's highlight: Dr. Dr. GPCR University Our first Dr. Kenakin and Dr. GPCR Complimentary one-year Dr. Dr. Receptor Gpr-1 Is Important for the Growth and Nutritional Metabolism of an Invasive Bark Beetle Symbiont Fungi
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
As a valued Dr. featuring: A short, focused video A concise written summary with key takeaways Handpicked references by Dr Your Exclusive Premium Member Benefit: As a thank you for your continued support of the Dr. GPCR Ecosystem, we're giving Dr. Warmest Regards, The Dr. GPCR Team & Terry’s Desk
- Molecular creativity in drug discovery
GPCR Podcast: Leadership, Impact, and GPCR Signaling with Dr. Dr. Yamina’s open letter reflects on how Dr. I wish Dr. No matter where you are in your GPCR journey, Dr.
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
The Corner comes will live monthly AMA sessions with Dr. Kenakin. GPCR Updates Learn Pharmacology That Drives Discovery – From Dr. Explore Dr. This blog post breaks down Dr. Stay curious, The Dr. GPCR Team
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Secure Your Access Now ➤ 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. best for the sake of promoting more educational opportunities that are sorely needed in the field” — Dr GPCR University Learner Dr. GPCR Podcast - Surviving Discovery’s Gauntlet Dr. The Dr. GPCR Team Read Full Edition ➤
























